Akero Therapeutics, Inc.

NasdaqGS:AKRO 주식 보고서

시가총액: US$2.3b

Akero Therapeutics 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?


최근 내부자 거래

NasdaqGS:AKRO 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
10 Sep 24SellUS$45,501Andrew ChengIndividual1,738US$26.18
10 Sep 24SellUS$14,059Timothy RolphIndividual537US$26.18
10 Sep 24SellUS$16,729William WhiteIndividual639US$26.18
10 Sep 24SellUS$16,677Catriona YaleIndividual637US$26.18
10 Sep 24SellUS$14,870Jonathan YoungIndividual568US$26.18
11 Jun 24SellUS$178,728Andrew ChengIndividual7,894US$22.64
11 Jun 24SellUS$53,886Timothy RolphIndividual2,380US$22.64
11 Jun 24SellUS$12,883Patrick LamyIndividual569US$22.64
11 Jun 24SellUS$64,094William WhiteIndividual2,831US$22.64
11 Jun 24SellUS$63,961Catriona YaleIndividual2,825US$22.64
11 Jun 24SellUS$56,965Jonathan YoungIndividual2,516US$22.64
13 Mar 24SellUS$18,443Jonathan YoungIndividual651US$28.33
13 Mar 24SellUS$20,483Catriona YaleIndividual723US$28.33
13 Mar 24SellUS$20,511William WhiteIndividual724US$28.33
13 Mar 24SellUS$55,782Andrew ChengIndividual1,969US$28.33
13 Mar 24SellUS$17,536Timothy RolphIndividual619US$28.33
14 Dec 23SellUS$11,273Jonathan YoungIndividual543US$20.76
14 Dec 23SellUS$10,671Timothy RolphIndividual514US$20.76
14 Dec 23SellUS$12,394Catriona YaleIndividual597US$20.76
14 Dec 23SellUS$33,797Andrew ChengIndividual1,628US$20.76
14 Dec 23SellUS$12,684William WhiteIndividual611US$20.76
08 Dec 23BuyUS$1,982,940Logos Global Management, L.P.Company100,000US$19.85
01 Dec 23BuyUS$1,694,565Logos Global Management, L.P.Company100,000US$16.99

내부자 거래량

내부자 구매: AKRO insiders는 지난 3개월 동안 주식만 판매했습니다.


소유권 분석

AKRO 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
개인 내부자1,202,2011.55%
공공 기업2,525,2523.26%
VC/PE 기업5,233,9896.77%
헤지 펀드5,919,4357.65%
교육기관62,484,93080.8%

주식의 희석: 지난 해 주주 수는 희석되었으며, 총 발행 주식 수 25.3% 만큼 증가했습니다.


최대 주주

상위 25 주주가 회사의 93.59%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
11.3%
Wellington Management Group LLP
7,896,632US$258.5m54.4%0.04%
10.1%
Janus Henderson Group plc
7,077,478US$231.6m2.93%0.09%
8.48%
RTW Investments, LP
5,919,435US$193.7m8.97%2.55%
8.23%
BlackRock, Inc.
5,747,790US$188.1m2.88%데이터 없음
7.5%
General Atlantic Service Company, L.P.
5,233,989US$171.3m0%3.06%
7.32%
T. Rowe Price Group, Inc.
5,108,455US$167.2m-13.6%0.01%
5.27%
The Vanguard Group, Inc.
3,676,581US$120.3m-0.77%데이터 없음
4%
Alkeon Capital Management, LLC
2,791,437US$91.4m-0.08%0.63%
3.62%
Pfizer Inc.
2,525,252US$82.7m0%데이터 없음
3.59%
State Street Global Advisors, Inc.
2,502,946US$81.9m-6.93%데이터 없음
2.89%
AllianceBernstein L.P.
2,017,088US$66.0m5.73%0.02%
2.46%
Perceptive Advisors LLC
1,714,806US$56.1m14.3%1.18%
2.4%
Tavistock Life Sciences
1,676,733US$54.9m0%3.41%
2.25%
Geode Capital Management, LLC
1,571,012US$51.4m-2.97%데이터 없음
1.99%
Redmile Group, LLC
1,387,479US$45.4m-14.1%2.42%
1.88%
Point72 Asset Management, L.P.
1,313,361US$43.0m0%0.1%
1.57%
Baker Bros. Advisors LP
1,097,082US$35.9m0%0.32%
1.35%
Emerald Advisers, LLC
939,628US$30.8m-0.06%0.6%
1.34%
Rock Springs Capital Management LP
933,399US$30.6m-13.1%0.97%
1.15%
Logos Global Management, L.P.
800,000US$26.2m0%2.99%
1.09%
Yiheng Capital Management, L.P.
758,769US$24.8m-47.1%4.28%
1.03%
Long Focus Capital Management LLC
719,604US$23.6m0%1.91%
0.99%
Deep Track Capital, LP
689,784US$22.6m0%0.67%
0.92%
Silverarc Capital Management, LLC
639,840US$20.9m2.36%4.66%
0.84%
Northern Trust Global Investments
584,584US$19.1m-0.56%데이터 없음